» Articles » PMID: 30176378

Cortisol Levels and Cognitive Profile in Major Depression: A Comparison of Currently and Previously Depressed Patients

Overview
Date 2018 Sep 4
PMID 30176378
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The association between depressive symptoms and elevated cortisol levels, and depression and cognitive functioning, has been less robust in outpatients with symptoms in the mild to moderate range. Furthermore, the association between elevated cortisol levels and cognitive functioning is unclear. In the present study, currently depressed (n = 37), previously depressed (n = 81) and never depressed controls (n = 50) were assessed on a range of neuropsychological measures. Salivary cortisol was measured in the morning and evening. Participants with current depression were non-hospitalized and had symptoms predominately in the mild to moderate range. Elevated salivary evening cortisol, but not morning cortisol, was significantly related to depressive symptoms. The difference in cortisol levels between the previously depressed group and the never depressed controls was not significant. The groups had significantly different cognitive profiles, with the currently depressed performing poorer on tasks related to working memory compared to the never depressed controls. Both the currently and previously depressed performed worse on attentional tasks. The findings indicate that outpatients with mild to moderate depression have elevated cortisol levels and limited mild cognitive impairments. Furthermore, mild impairments in attention may persist after remission, indicating that this could be a trait-marker in depression. The present study did not find support for a significant relationship between cortisol and cognitive functioning.

Citing Articles

a Possible Treatment for Depressive Disorders.

Mata-Bermudez A, Diaz-Ruiz A, Silva-Garcia L, Gines-Francisco E, Noriega-Navarro R, Rios C Neurol Int. 2024; 16(6):1509-1527.

PMID: 39585071 PMC: 11587415. DOI: 10.3390/neurolint16060112.


Plasma Neurotrophic Factor Levels are not Associated with the Severity of Depression: Prospective Pilot Study.

Zorkina Y, Syunyakov T, Abramova O, Yunes R, Pavlichenko A, Pavlov K Consort Psychiatr. 2024; 2(4):13-22.

PMID: 39045452 PMC: 11262070. DOI: 10.17816/CP110.


Anxiolytic and Antidepressant Effect of on Animal Models.

Munawwar R, Sarfaraz S, Ikram R, Zehra T, Anser H, Ali H Scientifica (Cairo). 2024; 2024:5710969.

PMID: 38690099 PMC: 11060873. DOI: 10.1155/2024/5710969.


Hesperidin reduces depressive symptoms in post-coronary artery bypass graft patients with mild depression.

Khorasanian A, Jazayeri S, Omidi N, Booyani Z, Morvaridi M, Tehrani-Doost M Food Sci Nutr. 2023; 11(12):7742-7750.

PMID: 38107143 PMC: 10724602. DOI: 10.1002/fsn3.3692.


Acute or Chronic Exposure to Corticosterone Promotes Wakefulness in Mice.

Yao Z, Zhang B, Chen H, Jiang X, Qu W, Huang Z Brain Sci. 2023; 13(10).

PMID: 37891839 PMC: 10605150. DOI: 10.3390/brainsci13101472.